close
close

Calculating the fair value of Exponent, Inc. (NASDAQ:EXPO)

Key findings

  • Exponent’s estimated fair value is $81.36 based on 2-step Free Cash Flow to Equity
  • Exponent’s share price of $97.40 suggests that the price is at a similar level to the estimated fair value.
  • The analyst price target of $94.00 for EXPO is 16% above our fair value estimate

How far is Exponent, Inc. (NASDAQ:EXPO) from its intrinsic value? Using the most recent financial data, we will check if the stock is fairly valued by projecting its future cash flows and then discounting them to today’s value. The Discounted Cash Flow (DCF) model is the tool we will use for this. It may sound complicated, but it’s actually quite simple!

However, keep in mind that there are many ways to estimate the value of a company, and a DCF is just one of them. If you want to learn more about intrinsic value, you should check out Simply Wall St’s analysis model.

Check out our latest analysis for Exponent

Step by step through the calculation

We will use a two-stage DCF model which, as the name suggests, considers two phases of growth. The first stage is generally a higher growth phase that stabilizes toward the terminal value captured in the second “steady growth” stage. First, we need to get estimates of the next ten years of cash flows. Since we don’t have analyst estimates of free cash flow available, we extrapolated the previous free cash flow (FCF) from the company’s last reported value. We assume that companies with shrinking free cash flow will slow their rate of shrinkage and that companies with growing free cash flow will slow their growth rate over this period. We do this to account for the fact that growth tends to slow more in the early years than in later years.

In general, we assume that a dollar today is worth more than a dollar in the future. Therefore, we discount the value of these future cash flows to their estimated value in today’s dollars:

Estimation of free cash flow (FCF) over 10 years

2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Leveraged FCF (in million US dollars) 144.5 million US dollars 154.8 million US dollars 163.6 million US dollars 171.3 million US dollars 178.2 million US dollars 184.4 million US dollars 190.3 million US dollars 195.9 million US dollars 201.3 million US dollars 206.6 million US dollars
Source of growth rate estimate Estimated at 9.16% Estimated at 7.12% Estimated at 5.70% Estimated at 4.70% Estimated at 4.01% Estimated at 3.52% Estimated at 3.18% Estimated at 2.94% Estimated at 2.77% Estimated at 2.65%
Present value (in million US dollars), discounted at 6.4% 136 US dollars 137 US dollars 136 US dollars 134 US dollars 131 US dollars 127 US dollars 123 US dollars 119 euros 115 US dollars 111 US dollars

(“Est” = FCF growth rate, estimated by Simply Wall St)
Present value of 10-year cash flow (PVCF) = 1.3 billion US dollars

After calculating the present value of future cash flows in the first 10-year period, we need to calculate the terminal value that takes into account all future cash flows after the first period. The Gordon growth formula is used to calculate the terminal value at a future annual growth rate equal to the 5-year average of the 10-year Treasury yield of 2.4%. We discount the terminal cash flows to today’s value at a cost of equity of 6.4%.

Final value (TV)= FCF2034 × (1 + g) ÷ (r – g) = $207 million × (1 + 2.4%) ÷ (6.4% – 2.4%) = $5.3 billion

Present value of terminal value (PVTV)= TV / (1 + r)10= 5.3 billion US dollars ÷ (1 + 6.4%)10= 2.9 billion US dollars

Total value is the sum of the next ten years’ cash flows plus the discounted terminal value, which gives the total value of equity, which in this case is $4.1 billion. To get the intrinsic value per share, we divide that by the total number of shares outstanding. Relative to the current share price of $97.4, the company is about fair value at the time of writing. However, valuations are imprecise instruments, much like a telescope – move a few degrees and you end up in another galaxy. Keep this in mind.

NasdaqGS:EXPO Discounted Cash Flow July 12, 2024

Important assumptions

We would like to point out that the main inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don’t have to agree with these inputs, I recommend repeating the calculations yourself and playing around with them. The DCF also does not take into account the possible cyclicality of an industry or a company’s future capital needs and therefore does not provide a complete picture of a company’s potential performance. Since we consider Exponent as potential shareholders, the cost of equity is used as the discount rate and not the cost of capital (or weighted average cost of capital, WACC) which takes debt into account. In this calculation, we used 6.4%, which is based on a leveraged beta of 0.869. Beta is a measure of a stock’s volatility relative to the overall market. We get our beta from the industry average beta of globally comparable companies with an imposed limit of between 0.8 and 2.0, which is a reasonable range for a stable company.

SWOT analysis for Exponent

Strength

  • Dividends are covered by earnings and cash flows.
weakness

  • Revenues have declined over the past year.
  • Compared to the top 25% dividend payers in the professional services market, the dividend is low.
  • Expensive based on P/E and estimated fair value.
Opportunity

  • Annual revenues are expected to increase over the next three years.
Danger

  • According to forecasts, annual earnings will grow more slowly than in the American market.

Next Steps:

Although the DCF calculation is important, ideally it should not be the only analysis you look at for a company. It is not possible to get a foolproof valuation using a DCF model. Rather, it should be viewed as a guide to “what assumptions need to be true for this stock to be under/overvalued.” For example, if the terminal value growth rate is adjusted slightly, it can dramatically change the overall result. For Exponent, there are three relevant factors you should examine:

  1. Risks: Every company has them, and we have found 1 warning sign for Exponent You should know about this.
  2. Future income: How is EXPO’s growth rate compared to competitors and the overall market? Learn more about analyst consensus numbers for the coming years by using our free chart of analyst growth expectations.
  3. Other solid companies: Low debt, high returns on equity, and good past performance are the foundation of a strong company. Check out our interactive list of stocks with solid business fundamentals to see if there are any other companies you may not have considered!

PS. The Simply Wall St app runs a discounted cash flow valuation for every stock on the NASDAQGS every day. If you want to find the calculation for other stocks, just search here.

Valuation is complex, but we help simplify it.

Find out if Exponent is potentially overvalued or undervalued by reading our comprehensive analysis, which includes: Fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View free analysis

Do you have feedback on this article? Are you concerned about the content? Get in touch directly from us. Alternatively, send an email to editorial-team (at) simplywallst.com.

This Simply Wall St article is of a general nature. We comment solely on the basis of historical data and analyst forecasts, using an unbiased methodology. Our articles do not constitute financial advice. It is not a recommendation to buy or sell any stock and does not take into account your objectives or financial situation. Our goal is to provide you with long-term analysis based on fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Simply Wall St does not hold any of the stocks mentioned.

Valuation is complex, but we help simplify it.

Find out if Exponent is potentially overvalued or undervalued by reading our comprehensive analysis, which includes: Fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View free analysis

Do you have feedback on this article? Are you interested in the content? Contact us directly. Alternatively, send an email to [email protected]